This August 2020 photo provided by Dr. Se-Jin Lee shows a normal mouse and a “twice-muscled” mouse developed at the The Jackson Laboratory of the University of Connecticut School of Medicine in Farmington, Conn. Findings published on Monday, Sept. 7, 2020, show that muscle-bound mice, similar to the one pictured, held on to their bodybuilder-type physiques during a one month space mission. (Dr. Se-Jin Lee/University of Connecticut School of Medicine via AP)
By Marcia Dunn
Bulked-up, mutant "mighty mice" held onto their muscle during a monthlong stay at the International Space Station, returning to Earth with ripped bodybuilder physiques, scientists reported Monday.
The findings hold promise for preventing muscle and bone loss in astronauts on prolonged space trips like Mars missions, as well as people on Earth who are confined to a bed or need wheelchairs.
A research team led by Dr. Se-Jin Lee of the Jackson Laboratory in Connecticut sent 40 young female black mice to the space station in December, launching aboard a SpaceX rocket.
In a paper published in the Proceedings of the National Academy of Sciences, Lee said the 24 regular untreated mice lost considerable muscle and bone mass in weightlessness as expected — up to 18%.
But the eight genetically engineered "mighty mice" launched with double the muscle maintained their bulk. Their muscles appeared to be comparable to similar "mighty mice" that stayed behind at NASA's Kennedy Space Center.
In addition, eight normal mice that received "mighty mouse" treatment in space returned to Earth with dramatically bigger muscles. The treatment involves blocking a pair of proteins that typically limit muscle mass.
A SpaceX capsule brought all 40 mice back in good condition, parachuting into the Pacific off the California coast in January. Some of the ordinary mice were injected with the "mighty mice" drug after returning and quickly built up more muscle than their untreated companions, Lee said.
The scientists completed the experiment just as the coronavirus was hitting the U.S.
"The only silver lining of COVID is that we had time to write it up very intensively" and submit the results for publication, said Dr. Emily Germain-Lee of Connecticut Children's Medical Center, Lee's wife who also took part in the study. Both are affiliated with the University of Connecticut.
While encouraged by their findings, the couple said much more work needs to be done before testing the drug on people to build up muscle and bone, without serious side effects.
"We're years away. But that's how everything is when you go from mouse to human studies," Germain-Lee said.
Lee said the experiment pointed out other molecules and signaling pathways worth investigating — "an embarrassment of riches ... so many things we'd like to pursue." His next step: possibly sending more "mighty mice" to the space station for an even longer stay.
Three NASA astronauts looked after the space mice, performing body scans and injections: Christina Koch and Jessica Meir, who performed the first all-female spacewalk last fall, and Andrew Morgan. They are listed as co-authors.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
2021 has been a year filled with extreme weather conditions. Hundreds of thousands of people recently saw the effects of massive tornados that swept across six states. Now, experts say climate change could have played a major role. Jennifer Marlon, research scientist and lecturer at the Yale School of the Environment, joins Cheddar News to discuss.
Anthony Tall, sports agent and president of Miracle Sports Agency, joins Cheddar News to talk about the challenges professional sports leagues are facing amid a surge in coronavirus cases across the U.S.
Extreme weather hit all of us in 2021. Deadly heat hit parts of the U.S. that normally don't even need air conditioning. More than 52,000 wildfires broke out, a terrifying example of what can happen when extreme heat mixes with drought. Hurricane Ida was so powerful it actually briefly reversed the flow of the Mississippi River. Cheddar News did a deep dive into this year's unbelievable weather and how climate change may have impacted it.
With the New Year just around the corner, many people will be making new health and fitness goals. However, after the initial January push, it's easy to drop your resolutions and go back to your old habits. Joan Ifland, CEO of Food Addiction Reset, discusses her best tips for following through with New Year's Resolutions.
Carlo and Baker preview President Biden's address to the nation as Omicron becomes the new dominant Covid strain. Plus, Trump gets booed for getting his booster and the White House gets a new puppy.
Alinda Mashiku, Conjunction Analysis and Risk Assessment Deputy Manager at the NASA Goddard Space Flight Center, joins Future of Space: Humankind's Leap Forward to explain how space debris is threatening operations in space at a time when more satellites are being deployed.
Marshall Smith, Senior Vice President of Space Systems at Nanoracks and Kirk Shireman, Vice President of the Lunar Exploration Campaign at Lockheed Martin join Future of Space: Humankind's Leap Forward to discuss upcoming plans for developing their Starlab commercial space station after being awarded a $160 million contract by NASA.
The CDC recently endorsed the advisory committee's recommendation that people should receive the Pfizer or Moderna COVID vaccines over the Johnson & Johnson shot, leaving some questions and concerns for the public. Epidemiologist Dr. Eric Feigl-Ding, spoke to Cheddar about the shift in the agency's stance, and what it might mean. "If you already have it, any side effects are already long past," he said. "Going forward is what they're saying. That getting a booster you should get the Moderna or the Pfizer booster, and I don't think they're encouraging anyone to get de novo Johnson & Johnson as their first shot anymore."
